Management Team
Mr. Baharaff is the co-founder of Galmed Pharmaceuticals Ltd., and has served as a CFO since its inception in 2000 and as CEO since 2012. He holds a Bachelor of Science degree from the University of London (LSE) and LLB and MA degrees from Cambridge University. Mr. Baharaff has held a number of Directorships including a SVP position at Isramex Projects Ltd., and T+M Trusteeship & Management . He also serves as a Director at the Tel-Aviv Museum of Arts, chairing the educational activities.
Dr. Halpern, is a Medical Advisor at CH Health, a private venture capital Israeli company. She holds a Medical Degree from Hadassa Medical School, the Hebrew University, Jerusalem and an M.A. in Philosophy from the Tel Aviv University. She specialized in Family Medicine. Since 2000, Dr. Halpern works in the Pharmaceutical Industry, until 2010 as a Medical Director for Teva Pharmaceutical Industries, in Israel and in the International Group and for the last two years with Galmed. Her experience covers conducting clinical trials, as well as medical and ethical aspects of drug marketing.
Mr. Morris joined us in 2013. He has served in various senior positions at large companies, including as Vice President of Finance and Operations at various portfolio companies of the Infinity Group, a privately-owned business and investment venture holding company, from 2007 to the present. Prior to 2007, Mr. Morris served as Vice President of Finance at Elam EL Industries Ltd., producer of electroluminescent lighting, and its United States, Hong Kong and British Virgin Islands subsidiaries from 1997 until 2006, and as Vice President of Finance at Compubyte Computers (1986) Ltd. from 1994 to 1997. Mr. Morris has also served and continues to serve as a director of several companies, including Mango DSP, Inc., from 2007 to date, and Mate Intelligent Video 2009 Ltd., from 2009 to date. Mr. Morris holds a Bachelor of Science degree in Accounting from Northeastern University, which was awarded in 1988.
Dr. Graham has over 25 years’ experience within the pharmaceutical industry and has worked for several different companies including Glaxo, Merck & Co, IVAX and Amgen. She has held a number of Directorships including European Director of Regulatory Affairs at Amgen. Dr. Graham founded Diamond BioPharm Limited in 2005, which is a leading technical and scientific consulting group of companies serving the biotechnology and pharmaceutical industry. Dr. Graham has direct experience with many types of products including biotechnology, gene-therapy, new chemical entities and generics. Dr. Graham also has a wealth of experience and expertise when it comes to the regulatory and product development issues associated with medicinal product for rare indications. Her experience covers products at all stages of development ranging from preclinical to registration.